revealed that, in patients with progressive MS and longstanding disease, white matter plaques were consistently positive for complement proteins (C3, Factor B, C1q), activation products (C3b, iC3b, C4d, TCC) and regulators (factor H, C1inh, Clusterin) (25). Here, VTN is linked to myeloid sarcoma.